Literature DB >> 9200628

The negative side of cost-effectiveness analysis.

A A Stinnett, J Mullahy.   

Abstract

Mesh:

Year:  1997        PMID: 9200628

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 2.  Willingness to pay as a measure of health benefits.

Authors:  M V Bala; J A Mauskopf; L L Wood
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

3.  Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

Authors:  P M Clarke; A M Gray; A Briggs; R J Stevens; D R Matthews; R R Holman
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

4.  Median-Based Incremental Cost-Effectiveness Ratio (ICER).

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Stat Theory Pract       Date:  2012-08-10

5.  Cost-Utility of Home-Based Fatigue Self-Management versus Usual Care for the Treatment of Chronic Fatigue Syndrome.

Authors:  Hongdao Meng; Fred Friedberg
Journal:  Fatigue       Date:  2017-06-30

6.  Cost-effectiveness of chronic fatigue self-management versus usual care: a pilot randomized controlled trial.

Authors:  Hongdao Meng; Fred Friedberg; Melissa Castora-Binkley
Journal:  BMC Fam Pract       Date:  2014-11-25       Impact factor: 2.497

Review 7.  Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-11-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.